| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Gastrointestinal Cancer
Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo
Cancer Res Treat. 2021;53(3):703-713.   Published online December 1, 2020    DOI: https://doi.org/10.4143/crt.2020.805
                              Supplementary      
Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo
Cancer Res Treat. 2020;52(1):254-262.   Published online July 9, 2019    DOI: https://doi.org/10.4143/crt.2019.190
                              Supplementary         Cited By 8
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang
Cancer Res Treat. 2018;50(4):1324-1330.   Published online January 8, 2018    DOI: https://doi.org/10.4143/crt.2017.526
                              Supplementary         Cited By 13
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen
Changhoon Yoo, Bum Jun Kim, Kyu-pyo Kim, Jae-Lyun Lee, Tae Won Kim, Baek-Yeol Ryoo, Heung-Moon Chang
Cancer Res Treat. 2017;49(3):759-765.   Published online November 9, 2016    DOI: https://doi.org/10.4143/crt.2016.371
                              Supplementary         Cited By 19
Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX
Mi-Jung Kim, Sae-Won Han, Dae-Won Lee, Yongjun Cha, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Se Hyung Kim, Seock-Ah Im, Yung-Jue Bang, Tae-You Kim
Cancer Res Treat. 2016;48(3):990-997.   Published online January 14, 2016    DOI: https://doi.org/10.4143/crt.2015.296
                              Supplementary         Cited By 8
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
Hyun Sun Woo, Kyoung Hwa Lee, Phill Hoon Yoon, Su Ji Kim, Inkeun Park, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Dong Bok Shin, Sun Jin Sym
Cancer Res Treat. 2015;47(4):949-953.   Published online October 28, 2014    DOI: https://doi.org/10.4143/crt.2014.052
                                 Cited By 5
Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer after Treatment with 5-Fluorouracil/Leucovorin and Oxaliplatin: Case Report and Literature Review
Hyung Duk Kim, Kyung Sun Ha, In Sook Woo, Yun Hwa Jung, Chi Wha Han, Tae-Jung Kim
Cancer Res Treat. 2014;46(2):204-207.   Published online April 15, 2014    DOI: https://doi.org/10.4143/crt.2014.46.2.204
                                 Cited By 13
Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil
Jae Joon Han, Sun Kyung Baek, Jae Jin Lee, Gou Young Kim, Si-Young Kim, Suk-Hwan Lee
Cancer Res Treat. 2014;46(1):55-64.   Published online January 15, 2014    DOI: https://doi.org/10.4143/crt.2014.46.1.55
                                 Cited By 16
Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
Hee Jun Lee, Hee Seung Kim, Noh Hyun Park, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Song
Cancer Res Treat. 2013;45(1):40-47.   Published online March 31, 2013    DOI: https://doi.org/10.4143/crt.2013.45.1.40
                                 Cited By 11
Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies
Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang
Cancer Res Treat. 2012;44(4):235-241.   Published online December 31, 2012    DOI: https://doi.org/10.4143/crt.2012.44.4.235
                                 Cited By 19
Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Ji Soo Park, Jae Yun Lim, Seung Kyo Park, Min Kyung Kim, Hee Sung Ko, Sun Och Yoon, Jong Won Kim, Seung Ho Choi, Jae Yong Cho
Cancer Res Treat. 2011;43(4):236-243.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.236
                                 Cited By 14
Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer
Han Jo Kim, Jun Young Eun, Young Woo Jeon, Jina Yun, Kyoung Ha Kim, Se Hyung Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong-Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Park
Cancer Res Treat. 2011;43(3):154-159.   Published online September 30, 2011    DOI: https://doi.org/10.4143/crt.2011.43.3.154
                                 Cited By 5
A Retrospective Study of First-Line Combination Chemotherapy in Advanced Colorectal Cancer: A Korean Single-Center Experience
Soon Il Lee, Se Hoon Park, Do Hyoung Lim, Keon Woo Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
Cancer Res Treat. 2011;43(2):96-101.   Published online June 30, 2011    DOI: https://doi.org/10.4143/crt.2011.43.2.96
                                 Cited By 1
Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
Kyung Kee Baek, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
Cancer Res Treat. 2010;42(4):185-190.   Published online December 31, 2010    DOI: https://doi.org/10.4143/crt.2010.42.4.185
                                 Cited By 27
Outcomes of Modified FOLFOX-6 as First Line Treatment in Patients with Advanced Gastric Cancer in a Single Institution; Retrospective Analysis
Han Hong Lee, Hoon Hur, Soo Hong Kim, Ae Ryung Park, Wook Kim, Hae Myung Jeon
Cancer Res Treat. 2010;42(1):18-23.   Published online March 31, 2010    DOI: https://doi.org/10.4143/crt.2010.42.1.18
                                 Cited By 12
Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric Cancer
In Sil Choi, Do-Youn Oh, Byoung-Su Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Lee
Cancer Res Treat. 2007;39(3):99-103.   Published online September 30, 2007    DOI: https://doi.org/10.4143/crt.2007.39.3.99
                                 Cited By 17
Hypersensitivity Reactions to Oxaliplatin
Kyoung-Hwan Lee, Yong Jai Park, Eun Sun Kim, Hui Jeong Hwang, Byoung Yong Shim, Hoon-Kyo Kim
Cancer Res Treat. 2006;38(4):240-241.   Published online December 31, 2006    DOI: https://doi.org/10.4143/crt.2006.38.4.240
                                 Cited By 5
Phase II Study of Oxaliplatin, 5-fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as Second Line Therapy
Duk-Joo Lee, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Myung-Ju Ahn
Cancer Res Treat. 2006;38(4):201-205.   Published online December 31, 2006    DOI: https://doi.org/10.4143/crt.2006.38.4.201
                              
Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil and Low Dose Leucovorin in Patients with Advanced Colorectal Cancer
Yoon Mi Shin, Hae Suk Han, Seong Woo Lim, Byung Chul Kim, Kyung Suck Cheoi, Young Ook Eum, Seung Taek Kim, Ki Hyeong Lee
Cancer Res Treat. 2005;37(5):284-289.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.284
                                 Cited By 2
Oxaliplatin with Biweekly Low Dose Leucovorin and Bolus and Continuous Infusion of 5-fluorouracil (Modified FOLFOX 4) as a Salvage Therapy for Patients with Advanced Gastric Cancer
Sung-Hwan Suh, Hyuk-Chan Kwon, Ji-Hoon Jo, Young-Rak Cho, Bong-Gun Seo, Dong-Mee Lee, Sung-Hyun Kim, Jae-Seok Kim, Hyo-Jin Kim
Cancer Res Treat. 2005;37(5):279-283.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.279
                                 Cited By 11
Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer
Byoung Yong Shim, Kang Moon Lee, Hyeon-Min Cho, Hyun Jin Kim, Hong Joo Cho, Jinmo Yang, Jun-Gi Kim, Hoon-Kyo Kim
Cancer Res Treat. 2005;37(4):212-215.   Published online August 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.4.212
                                 Cited By 3
The Efficacy of a Modified Chronomodulated Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin in Advanced Colorectal Cancer (Preliminary Data)
Ji Young Park, Si-Young Kim, Jae Jin Lee, Hwi Joong Yoon, Kyung Sam Cho
Cancer Res Treat. 2004;36(3):199-204.   Published online June 30, 2004    DOI: https://doi.org/10.4143/crt.2004.36.3.199
                                 Cited By 1
Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer
Hyuk-Chan Kwon, Kyoung Tae Kim, Shin Ae Lee, Jong-Sung Park, Sung-Hyun Kim, Jae-Seok Kim, Hyo Jin Kim
Cancer Res Treat. 2004;36(2):115-120.   Published online April 30, 2004    DOI: https://doi.org/10.4143/crt.2004.36.2.115
                                 Cited By 6
Combination Chemotherapy of Oxaliplatin and Capecitabine in Patients with Metastatic Colorectal Cancer: a Pilot Study
Myung Ju Ahn, Ho Suck Oh, Jung Hye Choi, Young Yeul Lee, In Soon Kim, Il Young Choi, Oh Young Lee, Heung Woo Lee
Cancer Res Treat. 2003;35(5):407-410.   Published online October 31, 2003    DOI: https://doi.org/10.4143/crt.2003.35.5.407
         Cited By 1
Antitumor Activity of Oxaliplatin, 5-FU and Paclitaxel Given Alone or in Combination with ZD1839 in Human Gastric Carcinoma Cells in vitro
Ji Hyun Jang, Sang Hak Lee, Jin Hyoung Kang, Hee Sik Sun, Kazuto Nishio, Nagahiro Saijo, Hyo Jeong Kuh
Cancer Res Treat. 2002;34(5):372-381.   Published online October 31, 2002    DOI: https://doi.org/10.4143/crt.2002.34.5.372
         Cited By 1
A Phase II Study of Oxaliplatin Combined with 5-Fluorouracil and Leucovorin (Mayo Clinic Regimen) in 5-Fluorouracil Refractory Colorectal Cancer
Yee Zee Bae, Jae Hyuk Jung, Chang Hoon Moon, Seong Hyun Kim, Hyuk Chan Kwon, Jae Seok Kim, Hyo Jin Kim
Cancer Res Treat. 2002;34(3):218-222.   Published online June 30, 2002    DOI: https://doi.org/10.4143/crt.2002.34.3.218
         Cited By 4
Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5-Fluorouracil-Pretreated Patients with Metastatic Colorectal Cancer
Soo Mee Bang, Eun Kyung Cho, Jae Hwan Oh, Heung Moon Chang, Jin Seok Ahn, Jung Ae Lee, Young Iee Park, Myung Jue Ahn, Young Suk Park, Dong Bok Shin, Jae Hoon Lee
Cancer Res Treat. 2001;33(5):414-419.   Published online October 31, 2001    DOI: https://doi.org/10.4143/crt.2001.33.5.414
         Cited By 1
A Phase II Study of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5- Fluorouracil-Pretreated Metastatic Colorectal Cancer
Keun Seok Lee, Won Sup Lee, Hark Kyun Kim, Joo Young Jeong, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc. 2001;33(2):99-105.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI